There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular ...

This is a strategy that is so incredibly beneficial for highly compensated employees because they can’t contribute to a ...

It could come as soon as next year or take until the end of the decade, but one analyst is confident that Tesla Inc. will ...

Shares of Sandisk rose on plans to join the S&P 500 index, just months after its spinoff to become an independent public company. The stock rose 6.9% to $242.62 in after-hours trading on Monday.

Fluence Energy said 85% of the backlog included in its fiscal-year outlook was already secured. The stock rose 13% to $17.80 in after-hours trading Monday. Keysight Technologies logged higher revenue ...

Shares of Woodward rose after the company's fiscal fourth-quarter results and full-year sales outlook came in ahead of Wall Street's expectations, helped by growing demand for its aerospace offerings.

Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against ...

Nexstar and Sinclair’s stocks fell after President Trump went against his FCC head, saying that removing a cap on TV-station ...

A BNP analyst says Meta’s AI spending is necessary from a competitive standpoint — and will eventually pay off.

Shares of Amentum advanced after the company said fiscal fourth-quarter revenue jumped ahead of expectations. The stock rose 10% to $27.89 in after-hours trading Monday. Through the close the stock ...

Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration.

The Google parent’s stock is on a run — and that’s lifting shares of major suppliers including Broadcom, Celestica and ...